Inetetamab Clinical Trials
2 recruitingDrug
Phase 41Not Applicable1
Showing 1–2 of 2 trials
Recruiting
Phase 4
The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer
Metastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University200 enrolled1 locationNCT06641544
Recruiting
Not Applicable
A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer
Breast Neoplasm Female
Wang Ouchen154 enrolled1 locationNCT06234137